Wider ACB members and Roger Ekins
Apologies for late reply to this; only just read it as I haven't been at my desk much lately.
I'm not sure if the ACB has formally or informally lobbied on behalf of Roger, but isn't there someone on the ACB Council or Scientific Committee or whatever who could do so?
There does seem a trend that everything on the planet is driven by American lawyers. There seems little incentive to go through all the red tape only for the little guy to lose in the end.
Regards to all
Finlay
Finlay MacKenzie
NEQAS - Deputy Director and Consultant Clinical Scientist
Tel: +44 (0) 121 414 7300
Internal: 760047300
Email: [log in to unmask]
Web: http://www.uhb.nhs.uk
We're bringing the world's most advanced cancer treatments to Birmingham.
Find out more at www.qecancerappeal.org or text QEHB01 £5 to 70070 to donate £5 to our appeal.
Healthcare Scientists - University Hospitals Birmingham NHS Foundation Trust
East Wing, Institute of Research and Development, Birmingham Research Park, Vincent Drive,
Birmingham, B15 2SQ
ð Delivering the best in care
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of Roger Ekins
Sent: 06 June 2014 15:00
To: [log in to unmask]
Subject: Patented assay techniques
This is an unusual email insofar as it concerns a uniquely important patented technology that all ACB members will ultimately use but for which they will have to pay.
But most ACB members don't have the time or opportunity to conduct research, develop and patent new inventions in the field of clinical biochemistry, which is a pity.
But since ceasing to provide routine hormone assays as one of the original Supraregional Assay Service centres (as instructed by the UCL provost, who considered that such activity was inappropriate in a medical school), I and my co-workers have fortunately been able to continue studies on the effects of maternal hormones on fetal neurological development.
This has demanded the development of assay techniques, one or two of which have been relevant to clinical biochemists and which I have patented on behalf of UCL, primarily to protect the IP from foreign exploitation. Note that I have rejected any part of the royalties deriving from the patents to which I might be entitled according to UCL's rules, this element of the royalties being devoted to charity.
The attached Bullet document constitutes a brief summary of the fate of this patent of which the UK and EU scientific communities should be made aware as a warning. Also politicians, since it is totally useless to train more scientists if the government simply allows those scientists' inventions to slip through its fingers and to be unsupported.
--
With best regards to all,
Roger Ekins
Prof Roger Ekins, MA(Cantab) PhD DSc FRS
University College London
Phone +44 20 3108 6042
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|